Results 301 to 310 of about 197,639 (362)
Some of the next articles are maybe not open access.

Pancreatic steatosis

Current Opinion in Gastroenterology, 2019
Pancreatic steatosis is a clinical entity with emerging significance and impacts patient health in a multitude of ways. It has a high prevalence in the global population with predilections for different demographics by age, sex and ethnicity. Understanding the pathophysiology, clinical features and complications of this entity may be important to ...
Resham, Ramkissoon, Timothy B, Gardner
openaire   +2 more sources

Mirtazapine-induced steatosis

Int. Journal of Clinical Pharmacology and Therapeutics, 2017
Mirtazapine is a commonly used drug indicated for the treatment of severe depression. It works as a presynaptic α2-adrenoreceptor antagonist that increases central noradrenergic and serotonergic neurotransmission, and it is metabolized by the p450 cytochrome oxidase system.
Elin, Thomas   +4 more
openaire   +2 more sources

Hepatic Steatosis

Current Opinion in Clinical Nutrition & Metabolic Care, 2016
The high worldwide prevalence of nonalcoholic fatty liver disease (NAFLD) makes it a major public health issue. Amino acids offer a promising approach for its prevention, and several experimental studies highlight the nutritional importance of citrulline in this setting.
Prasanthi, Jegatheesan   +1 more
openaire   +3 more sources

Cytochrome P450 and Steatosis

Current Drug Metabolism, 2009
The term fatty liver identifies a liver in which lipids account for more than 5% of the liver's wet weight. When fat accumulates, the lipids primarily stored as triglycerides (TG) result in steatosis and provide substrates for lipid peroxidation. Accumulation of neutral lipids in hepatocytes leads to micro- and macro-vesicular steatosis and to balloon ...
María José, Gómez-Lechón   +2 more
openaire   +2 more sources

Imaging of Hepatic Steatosis

Seminars in Liver Disease, 2001
Hepatic steatosis is a common finding encountered during cross-sectional imaging examinations. This article reviews the imaging findings of hepatic steatosis as revealed by sonography, computed tomography, magnetic resonance imaging, and magnetic resonance spectroscopy.
E S, Siegelman, M A, Rosen
openaire   +2 more sources

Hypertension and hepatic steatosis

Current Hypertension Reports, 2008
Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic ...
Matthew J, Brookes   +2 more
openaire   +2 more sources

Animal Models of Steatosis

Seminars in Liver Disease, 2001
The lipid content of hepatocytes is regulated by the integrated activities of cellular enzymes that catalyze lipid uptake, synthesis, oxidation, and export. When "input" of fats into these systems (either because of increased fatty acid delivery, hepatic fatty acid uptake, or fatty acid synthesis) exceeds the capacity for fatty acid oxidation or export
A, Koteish, A M, Diehl
openaire   +2 more sources

Hepatitis C and steatosis

Clinics in Liver Disease, 2004
Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly impacts therapeutic response ...
Anouk, Dev   +2 more
openaire   +2 more sources

Steatosis in the Liver

Comprehensive Physiology, 2013
AbstractAccumulation of triacylglycerols within the cytoplasm of hepatocytes to the degree that lipid droplets are visible microscopically is called liver steatosis. Most commonly, it occurs when there is an imbalance between the delivery or synthesis of fatty acids in the liver and their disposal through oxidative pathways or secretion into the blood ...
David Q-H, Wang   +2 more
openaire   +2 more sources

Patomechanisms of hepatic steatosis

Orvosi Hetilap, 2010
Az elhízás és hozzá társuló kórállapotok, így az inzulinrezisztenciát kísérő nem alkoholos zsírmájbetegség a világ egészségügyi rendszereire jelentős terhet rónak. A betegség kialakulásának első lépése a májban történő trigliceridlerakódást kísérő elzsírosodás, amely később gyulladáshoz, illetve májzsugorhoz és májrákhoz is vezethet.
Péter, Fülöp, György, Paragh
openaire   +2 more sources

Home - About - Disclaimer - Privacy